InvestorsHub Logo
Followers 32
Posts 2200
Boards Moderated 0
Alias Born 09/01/2020

Re: Evil Rabbit post# 153708

Friday, 03/19/2021 10:50:44 PM

Friday, March 19, 2021 10:50:44 PM

Post# of 233295
Agreed. We are way undervalued. Look at NVAX. Their vaccine is not yet approved and they are at over $16B market cap. Plus they have a lot more competition in the vaccine space already than we do. In fact, we do not have any competition in critical covid patients. Moderna is close to $60B market cap. With one EUA (for critical covid), we ought to be minimum double digit share price right away. And once we have results from NASH, LH, update on HIV BLA, and other trials in the second half of this year, we will be in $20-30 range, IMO.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News